Progress in Vaccination of Prophylactic Human Papillomavirus Vaccine
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Progress in Vaccination of Prophylactic Human Papillomavirus Vaccine
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-07-10
DOI
10.3389/fimmu.2020.01434
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HPV vaccination and sexual behaviour in healthcare seeking young women in Luxembourg
- (2020) Camille Soudeyns et al. PeerJ
- Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020–99: a modelling study
- (2019) Kate T Simms et al. LANCET ONCOLOGY
- A cluster analysis of serious adverse event reports after human papillomavirus (HPV) vaccination in Danish girls and young women, September 2009 to August 2017
- (2019) Daniel Ward et al. Eurosurveillance
- Bivalent Human Papillomavirus (HPV) Vaccine Effectiveness Correlates With Phylogenetic Distance From HPV Vaccine Types 16 and 18
- (2019) Johannes A Bogaards et al. JOURNAL OF INFECTIOUS DISEASES
- A mixed two-dose vaccination schedule: Not enough evidence to support a policy change in Quebec
- (2019) Zeev Rosberger et al. VACCINE
- Efficacy, immunogenicity and safety of the AS04‐HPV‐16/18 vaccine in Chinese women aged 18‐25 years: End‐of‐study results from a phase II/III, randomised, controlled trial
- (2019) Feng‐Cai Zhu et al. Cancer Medicine
- Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus
- (2019) Zheng Quan Toh et al. Infection and Drug Resistance
- Cancers in Humans: A Lifelong Search for Contributions of Infectious Agents, Autobiographic Notes
- (2019) Harald zur Hausen Annual Review of Virology
- Current status of human papillomavirus vaccination in India's cervical cancer prevention efforts
- (2019) Rengaswamy Sankaranarayanan et al. LANCET ONCOLOGY
- Preferred product characteristics for therapeutic vaccines to improve tuberculosis treatment outcomes: Key considerations from World Health Organization consultations
- (2019) Johan Vekemans et al. VACCINE
- Predictors of Human Papillomavirus Vaccine Follow-Through Among Privately Insured US Patients
- (2018) Jennifer C. Spencer et al. AMERICAN JOURNAL OF PUBLIC HEALTH
- The role of human papillomavirus vaccines in cervical cancer: Prevention and treatment
- (2018) Giorgio Bogani et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- The clinical value of HPV E6/E7 and STAT3 mRNA detection in cervical cancer screening
- (2018) Yibing Fan et al. PATHOLOGY RESEARCH AND PRACTICE
- Human papillomavirus vaccination coverage in Luxembourg – Implications of lowering and restricting target age groups
- (2018) Ardashel Latsuzbaia et al. VACCINE
- Can a single dose of human papillomavirus (HPV) vaccine prevent cervical cancer? Early findings from an Indian study
- (2018) Rengaswamy Sankaranarayanan et al. VACCINE
- Factors Associated with HPV Vaccine Refusal among Young Adult Women after Ten Years of Vaccine Implementation
- (2018) Vincenzo Restivo et al. International Journal of Environmental Research and Public Health
- Cellular Immune Responses 6 Years Following 1, 2, or 3 Doses of Quadrivalent HPV Vaccine in Fijian Girls and Subsequent Responses to a Dose of Bivalent HPV Vaccine
- (2018) Zheng Quan Toh et al. Open Forum Infectious Diseases
- Human Papillomavirus Vaccines: Successes and Future Challenges
- (2018) Samara Perez et al. DRUGS
- Uptake of breast and cervical cancer screening in four Gulf Cooperation Council countries
- (2018) Vivian H.T. So et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Efficacy of quadrivalent human papillomavirus vaccine against persistent infection and genital disease in Chinese women: A randomized, placebo-controlled trial with 78-month follow-up
- (2018) Lihui Wei et al. VACCINE
- Urban-Rural Disparity in Cancer Incidence, Mortality, and Survivals in Shanghai, China, During 2002 and 2015
- (2018) Xiaopan Li et al. Frontiers in Oncology
- Corrigendum to “HPV vaccines—A review of the first decade” [Gynecol. Oncol. 146 (2017) 196–204]
- (2017) Diane M. Harper et al. GYNECOLOGIC ONCOLOGY
- HPV vaccines – A review of the first decade
- (2017) Diane M. Harper et al. GYNECOLOGIC ONCOLOGY
- Immunogenicity and safety of human papillomavirus (HPV) vaccination in Asian populations from six countries: a meta-analysis
- (2017) Didik Setiawan et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial
- (2017) Warner K Huh et al. LANCET
- Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study
- (2017) Kimberley Kavanagh et al. LANCET INFECTIOUS DISEASES
- HPV Vaccinations in Lublin Region, Poland
- (2017) Paweł Kalinowski et al. Postepy Higieny I Medycyny Doswiadczalnej
- Epidemiologic Evaluation of Human Papillomavirus Type Competition and the Potential for Type Replacement Post-Vaccination
- (2017) Joseph E. Tota et al. PLoS One
- Impact of partial bivalent HPV vaccination on vaccine-type infection: a population-based analysis
- (2016) K Cuschieri et al. BRITISH JOURNAL OF CANCER
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cervical Infection With Vaccine-Associated Human Papillomavirus (HPV) Genotypes as a Predictor of Acquisition and Clearance of Other HPV Infections
- (2016) Joseph E. Tota et al. JOURNAL OF INFECTIOUS DISEASES
- Human papillomavirus prevalence in unvaccinated heterosexual males following a national female vaccination program
- (2016) Dorothy A. Machalek et al. JOURNAL OF INFECTIOUS DISEASES
- Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus
- (2016) Jane J. Kim et al. JNCI-Journal of the National Cancer Institute
- Safety Profile of the 9-Valent HPV Vaccine: A Combined Analysis of 7 Phase III Clinical Trials
- (2016) Edson D. Moreira et al. PEDIATRICS
- Use of the nonavalent HPV vaccine in individuals previously fully or partially vaccinated with bivalent or quadrivalent HPV vaccines
- (2016) Pierre Van Damme et al. VACCINE
- A phase III clinical study to compare the immunogenicity and safety of the 9-valent and quadrivalent HPV vaccines in men
- (2016) Pierre Van Damme et al. VACCINE
- Manufacturing costs of HPV vaccines for developing countries
- (2016) Chaevia Clendinen et al. VACCINE
- Vaccine impact: Benefits for human health
- (2016) Mark Doherty et al. VACCINE
- Safety of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in adolescents aged 12–15 years: Interim analysis of a large community-randomized controlled trial
- (2016) Matti Lehtinen et al. Human Vaccines & Immunotherapeutics
- Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus
- (2016) Jane J. Kim et al. JNCI-Journal of the National Cancer Institute
- Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis
- (2016) Laia Bruni et al. Lancet Global Health
- Next generation prophylactic human papillomavirus vaccines
- (2015) John T Schiller et al. LANCET ONCOLOGY
- HPV-FASTER: broadening the scope for prevention of HPV-related cancer
- (2015) F. Xavier Bosch et al. Nature Reviews Clinical Oncology
- A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women
- (2015) Elmar A. Joura et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized, Double-Blind, Phase III Study of the Immunogenicity and Safety of a 9-Valent Human Papillomavirus L1 Virus-Like Particle Vaccine (V503) Versus Gardasil® in 9–15-Year-Old Girls
- (2015) Timo Vesikari et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Immunogenicity and Safety of a 9-Valent HPV Vaccine
- (2015) P. Van Damme et al. PEDIATRICS
- Preclinical refinements of a broadly protective VLP-based HPV vaccine targeting the minor capsid protein, L2
- (2015) Ebenezer Tumban et al. VACCINE
- Final report on exposure during pregnancy from a pregnancy registry for quadrivalent human papillomavirus vaccine
- (2015) Mary Ann Goss et al. VACCINE
- Canadian academic’s call for moratorium on HPV vaccine sparks controversy
- (2015) Owen Dyer BMJ-British Medical Journal
- Canadian academic’s call for moratorium on HPV vaccine sparks controversy
- (2015) Owen Dyer BMJ-British Medical Journal
- Effect of Different Human Papillomavirus Serological and DNA Criteria on Vaccine Efficacy Estimates
- (2014) Krystle A. Lang Kuhs et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Pooled analysis of large and long-term safety data from the human papillomavirus-16/18-AS04-adjuvanted vaccine clinical trial programme
- (2014) Maria-Genalin Angelo et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Immune response to the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose or 3-dose schedule up to 4 years after vaccination
- (2014) Barbara Romanowski et al. Human Vaccines & Immunotherapeutics
- Comparison of adaptive and innate immune responses induced by licensed vaccines for human papillomavirus
- (2014) Douglas M Herrin et al. Human Vaccines & Immunotherapeutics
- Human papillomavirus and cervical cancer
- (2013) Emma J Crosbie et al. LANCET
- Characteristics of HPV-Specific Antibody Responses Induced by Infection and Vaccination: Cross-Reactivity, Neutralizing Activity, Avidity and IgG Subclasses
- (2013) Mirte Scherpenisse et al. PLoS One
- Cross-roads in the classification of papillomaviruses
- (2013) Ethel-Michele de Villiers VIROLOGY
- Detection of rare and possibly carcinogenic human papillomavirus genotypes as single infections in invasive cervical cancer
- (2012) Daan Geraets et al. JOURNAL OF PATHOLOGY
- Development of AAVLP(HPV16/31L2) Particles as Broadly Protective HPV Vaccine Candidate
- (2012) Karen Nieto et al. PLoS One
- Human Papillomavirus Vaccine Introduction – The First Five Years
- (2012) Lauri E. Markowitz et al. VACCINE
- Correlation between levels of human papillomavirus (HPV)-16 and 18 antibodies in serum and cervicovaginal secretions in girls and women vaccinated with the HPV-16/18 AS04-adjuvanted vaccine
- (2011) Tino F. Schwarz et al. Human vaccines & immunotherapeutics
- Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
- (2011) Matti Lehtinen et al. LANCET ONCOLOGY
- Reported adverse events in girls aged 13–16 years after vaccination with the human papillomavirus (HPV)-16/18 vaccine in the Netherlands
- (2011) T.M. van’t Klooster et al. VACCINE
- Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection
- (2010) Sven-Eric Olsson et al. Human vaccines & immunotherapeutics
- Comparison of the immunogenicity and safety ofCervarix™ andGardasil®human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18–45 years
- (2010) Mark H. Einstein et al. Human vaccines & immunotherapeutics
- Genetic Variants in TAP Are Associated with High-Grade Cervical Neoplasia
- (2009) M. H. Einstein et al. CLINICAL CANCER RESEARCH
- A review of human carcinogens—Part B: biological agents
- (2009) Véronique Bouvard et al. LANCET ONCOLOGY
- Potent anti-HPV immune responses induced by tandem repeats of the HPV16 L2 (20–38) peptide displayed on bacterial thioredoxin
- (2009) Ivonne Rubio et al. VACCINE
- Immune response to human papillomavirus after prophylactic vaccination with AS04-adjuvanted HPV-16/18 vaccine: Improving upon nature
- (2008) Tino F. Schwarz et al. GYNECOLOGIC ONCOLOGY
- Syncope After Vaccination—United States, January 2005–July 2007
- (2008) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Risk of Female Human Papillomavirus Acquisition Associated with First Male Sex Partner
- (2008) Rachel L. Winer et al. JOURNAL OF INFECTIOUS DISEASES
- Human papillomavirus type distribution in women from Asia: a meta-analysis
- (2007) Y.-P. BAO et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started